{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:16:14Z","timestamp":1793412974693,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006196","name":"University of Oulu","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>High sensitivity C-reactive protein (hsCRP) is a sensitive marker of subclinical inflammation and has been proposed as a marker for predicting gestational diabetes in early pregnancy. However, data concerning the levels of hsCRP in early pregnancy are inconsistent. We aimed to determine hsCRP levels in early pregnancy and to examine the associations between hsCRP levels and the number of abnormal values in the oral glucose tolerance test and the type of hyperglycemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Early pregnancy serum hsCRP levels were analyzed in 776 women with gestational diabetes and 856 pregnant controls without diabetes. The mean gestational age at sampling was 10.7 weeks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Early pregnancy hsCRP levels were higher in women who later developed gestational diabetes compared to controls (geometric mean 3.71\u00a0mg\/L vs. 2.62\u00a0mg\/L). After adjustments, including those for maternal age and pre-pregnancy body mass index, the results remained significant. When compared to the lowest quartile of hsCRP, women in the other quartiles had 1.5-fold odds for gestational diabetes after adjustments. Furthermore, hsCRP levels were higher in women with two or three abnormal oral glucose tolerance test values compared to those with one abnormal value and among women with postprandial hyperglycemia compared to those with only fasting hyperglycemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Early pregnancy serum hsCRP levels were associated with subsequent gestational diabetes, and most with a higher number of abnormal values and postprandial hyperglycemia in the oral glucose tolerance test. These findings highlight the role of chronic inflammation and clustering of metabolic risk factors involved in gestational diabetes and its severity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13098-025-01843-0","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:40:11Z","timestamp":1752673211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Associations of early pregnancy high-sensitivity C-reactive protein levels with subsequent gestational diabetes: A Finnish gestational diabetes study"],"prefix":"10.1186","volume":"17","author":[{"given":"Shilpa","family":"Lingaiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"V\u00e4\u00e4r\u00e4sm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"\u00d6hman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Kajantie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Keikkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Mustaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"1843_CR1","doi-asserted-by":"crossref","unstructured":"Wang H, Li N, Chivese T et al. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group\u2019s Criteria. Diabetes Res Clin Pract.; 183.","DOI":"10.1016\/j.diabres.2021.109050"},{"key":"1843_CR2","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991\u20132002.","journal-title":"N Engl J Med"},{"key":"1843_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jama.2018.11628","volume":"320","author":"WL Lowe","year":"2018","unstructured":"Lowe WL, Scholtens DM, Lowe LP, et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA. 2018;320:1005\u201316.","journal-title":"JAMA"},{"key":"1843_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2337\/dc16-2397","volume":"40","author":"WH Tam","year":"2017","unstructured":"Tam WH, Ma RCW, Ozaki R, et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40:679\u201386.","journal-title":"Diabetes Care"},{"key":"1843_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1267-6","volume":"19","author":"ME Bianco","year":"2019","unstructured":"Bianco ME, Josefson JL. Hyperglycemia during pregnancy and Long-Term offspring outcomes. Curr Diab Rep. 2019;19:1\u20138.","journal-title":"Curr Diab Rep"},{"key":"1843_CR6","doi-asserted-by":"publisher","first-page":"108625","DOI":"10.1016\/j.diabres.2020.108625","volume":"171","author":"RA Dennison","year":"2021","unstructured":"Dennison RA, Chen ES, Green ME, et al. The absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis of 129 studies. Diabetes Res Clin Pract. 2021;171:108625.","journal-title":"Diabetes Res Clin Pract"},{"key":"1843_CR7","doi-asserted-by":"publisher","first-page":"m1361","DOI":"10.1136\/bmj.m1361","volume":"369","author":"E Vounzoulaki","year":"2020","unstructured":"Vounzoulaki E, Khunti K, Abner SC, et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020;369:m1361.","journal-title":"BMJ"},{"key":"1843_CR8","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1210\/jc.2009-1075","volume":"95","author":"J Pirkola","year":"2010","unstructured":"Pirkola J, Pouta A, Bloigu A, et al. Prepregnancy overweight and gestational diabetes as determinants of subsequent diabetes and hypertension after 20-year follow-up. J Clin Endocrinol Metab. 2010;95:772\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1843_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/09513590.2016.1198764","volume":"32","author":"H Hakkarainen","year":"2016","unstructured":"Hakkarainen H, Huopio H, Cederberg H, et al. The risk of metabolic syndrome in women with previous GDM in a long-term follow-up. Gynecol Endocrinol. 2016;32:920\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"1843_CR10","doi-asserted-by":"publisher","first-page":"e1002488","DOI":"10.1371\/journal.pmed.1002488","volume":"15","author":"B Daly","year":"2018","unstructured":"Daly B, Toulis KA, Thomas N, et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study. PLoS Med. 2018;15:e1002488.","journal-title":"PLoS Med"},{"key":"1843_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","volume":"62","author":"CK Kramer","year":"2019","unstructured":"Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62:905\u201314.","journal-title":"Diabetologia"},{"key":"1843_CR12","doi-asserted-by":"publisher","unstructured":"Ding TT, Xiang J, Luo BR et al. Relationship between the IADPSG-criteria-defined abnormal glucose values and adverse pregnancy outcomes among women having gestational diabetes mellitus: A retrospective cohort study. Medicine (United States).; 97. Epub ahead of print 1 October 2018. https:\/\/doi.org\/10.1097\/MD.0000000000012920.","DOI":"10.1097\/MD.0000000000012920"},{"key":"1843_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00592-021-01815-6","volume":"59","author":"B Bhavadharini","year":"2022","unstructured":"Bhavadharini B, Anjana RM, Deepa M, et al. Association between number of abnormal glucose values and severity of fasting plasma glucose in IADPSG criteria and maternal outcomes in women with gestational diabetes mellitus. Acta Diabetol. 2022;59:349\u201357.","journal-title":"Acta Diabetol"},{"key":"1843_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/aogs.14999","volume":"104","author":"S Etel\u00e4inen","year":"2025","unstructured":"Etel\u00e4inen S, Keikkala E, Lingaiah S, et al. Perinatal and neonatal outcomes in gestational diabetes: the importance of the number of abnormal values in an oral glucose tolerance test. Acta Obstet Gynecol Scand. 2025;104:130\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1843_CR15","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3390\/ijms19113342","volume":"19","author":"JF Plows","year":"2018","unstructured":"Plows JF, Stanley JL, Baker PN, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19:3342.","journal-title":"Int J Mol Sci"},{"key":"1843_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/dme.12381","volume":"31","author":"PM Catalano","year":"2014","unstructured":"Catalano PM. Trying to understand gestational diabetes. Diabet Med. 2014;31:273\u201381.","journal-title":"Diabet Med"},{"key":"1843_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI200524531","volume":"115","author":"TA Buchanan","year":"2005","unstructured":"Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115:485\u201391.","journal-title":"J Clin Invest"},{"key":"1843_CR18","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793\u2013801.","journal-title":"J Clin Invest"},{"key":"1843_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ogc.2007.04.001","volume":"34","author":"AC Richardson","year":"2007","unstructured":"Richardson AC, Carpenter MW. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am. 2007;34:213\u201324.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"1843_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98\u2013107.","journal-title":"Nat Rev Immunol"},{"key":"1843_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/gad.346312.120","volume":"35","author":"YS Lee","year":"2021","unstructured":"Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev. 2021;35:307\u201328.","journal-title":"Genes Dev"},{"key":"1843_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, et al. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55:31\u201355.","journal-title":"Immunity"},{"key":"1843_CR23","doi-asserted-by":"crossref","unstructured":"Wang Z, Shen XH, Feng WM et al. Analysis of Inflammatory Mediators in Prediabetes and Newly Diagnosed Type 2 Diabetes Patients. J Diabetes Res. 2016; 2016: 7965317.","DOI":"10.1155\/2016\/7965317"},{"key":"1843_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2265.2012.04384.x","volume":"78","author":"P Marques-Vidal","year":"2013","unstructured":"Marques-Vidal P, Bastardot F, Von K\u00e4nel R, et al. Association between Circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf). 2013;78:232\u201341.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1843_CR25","doi-asserted-by":"publisher","first-page":"19725","DOI":"10.1161\/JAHA.120.019725","volume":"10","author":"JJ Ruiz-Ramie","year":"2021","unstructured":"Ruiz-Ramie JJ, Barber JL, Lloyd-Jones DM, et al. Cardiovascular health trajectories and elevated C-reactive protein: the CARDIA study. J Am Heart Assoc. 2021;10:19725.","journal-title":"J Am Heart Assoc"},{"key":"1843_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2337\/diacare.26.3.819","volume":"26","author":"M Wolf","year":"2003","unstructured":"Wolf M, Sandler L, Hsu K, et al. First-Trimester C-Reactive protein and subsequent gestational diabetes. Diabetes Care. 2003;26:819\u201324.","journal-title":"Diabetes Care"},{"key":"1843_CR27","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3109\/14767058.2014.973397","volume":"28","author":"AS Ozgu-Erdinc","year":"2015","unstructured":"Ozgu-Erdinc AS, Yilmaz S, Yeral MI, et al. Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal Med. 2015;28:1957\u201362.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1843_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/AOG.0b013e3182a0c88b","volume":"122","author":"JP Rasanen","year":"2013","unstructured":"Rasanen JP, Snyder CK, Rao PV, et al. Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes. Obstet Gynecol. 2013;122:586\u201394.","journal-title":"Obstet Gynecol"},{"key":"1843_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.metabol.2015.10.029","volume":"65","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki A, Visser GHA, Krithinakis K, et al. First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation. Metabolism. 2016;65:131\u20137.","journal-title":"Metabolism"},{"key":"1843_CR30","doi-asserted-by":"publisher","first-page":"e0224739","DOI":"10.1371\/journal.pone.0224739","volume":"14","author":"N Yu","year":"2019","unstructured":"Yu N, Cui H, Chen X, et al. Changes of serum pentraxin-3 and hypersensitive CRP levels during pregnancy and their relationship with gestational diabetes mellitus. PLoS ONE. 2019;14:e0224739.","journal-title":"PLoS ONE"},{"key":"1843_CR31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/ije\/dyaa039","volume":"49","author":"E Keikkala","year":"2020","unstructured":"Keikkala E, Mustaniemi S, Koivunen S, et al. Cohort profile: the Finnish gestational diabetes (FinnGeDi) study. Int J Epidemiol. 2020;49:762\u20133.","journal-title":"Int J Epidemiol"},{"key":"1843_CR32","unstructured":"Gestational diabetes. Current Care Guidelines, Working group set up by the Finnish Medical Society Duodecim, the Medical Advisory Board of the Finnish Diabetes Association and the Finnish Gynecological Association. 2008. Finnish Medical Society Duodecim, www.kaypahoito.fi (accessed 15 December 2024)."},{"key":"1843_CR33","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.2337\/dc07-S042","volume":"30","author":"American Diabetes Association","year":"2007","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30:S42\u20137.","journal-title":"Diabetes Care"},{"key":"1843_CR34","unstructured":"Finnish Institute for Health Welfare (THL). Care Register for Health Care. https:\/\/thl.fi\/en\/statistics-and-data\/data-and-services\/register-descriptions\/care-register-for-health-care (accessed 15 December 2024)."},{"key":"1843_CR35","unstructured":"Finnish Institute for Health and Welfare (THL). Register of Primary Health Care visits, https:\/\/thl.fi\/en\/statistics-and-data\/data-and-services\/register-descriptions\/register-of-primary-health-care-visits (accessed 15 December 2024)."},{"key":"1843_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation. 2003;107:499\u2013511.","journal-title":"Circulation"},{"key":"1843_CR37","doi-asserted-by":"publisher","unstructured":"Myers GL, Rifai N, Tracy RP et al. CDC\/AHA workshop on markers of inflammation and cardiovascular disease. Circulation.; 110. Epub ahead of print 21 December 2004. https:\/\/doi.org\/10.1161\/01.CIR.0000148980.87579.5E","DOI":"10.1161\/01.CIR.0000148980.87579.5E"},{"key":"1843_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.archger.2014.10.002","volume":"60","author":"M Kuoppam\u00e4ki","year":"2015","unstructured":"Kuoppam\u00e4ki M, Salminen M, Vahlberg T, et al. High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: A prospective 9-year follow-up study. Arch Gerontol Geriatr. 2015;60:112\u20137.","journal-title":"Arch Gerontol Geriatr"},{"key":"1843_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1089\/met.2015.0118","volume":"14","author":"CM Hwu","year":"2016","unstructured":"Hwu CM, Lin YC, Lin MW. High levels of C-Reactive protein are positively associated with isolated postchallenge hyperglycemia in postmenopausal women. Metab Syndr Relat Disord. 2016;14:334\u20139.","journal-title":"Metab Syndr Relat Disord"},{"key":"1843_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/EJE-16-0528","volume":"175","author":"C Herder","year":"2016","unstructured":"Herder C, F\u00e6rch K, Carstensen-Kirberg M, et al. Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study. Eur J Endocrinol. 2016;175:367\u201377.","journal-title":"Eur J Endocrinol"},{"key":"1843_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.arcmed.2013.11.004","volume":"45","author":"F Guerrero-Romero","year":"2014","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M. Association of C-reactive protein levels with fasting and postload glucose levels according to glucose tolerance status. Arch Med Res. 2014;45:70\u20135.","journal-title":"Arch Med Res"},{"key":"1843_CR42","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2337\/diacare.28.5.1211","volume":"28","author":"Y Doi","year":"2005","unstructured":"Doi Y, Kiyohara Y, Kubo M, et al. Relationship between C-Reactive protein and glucose levels in Community-Dwelling subjects without diabetesthe Hisayama study. Diabetes Care. 2005;28:1211\u20133.","journal-title":"Diabetes Care"},{"key":"1843_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1464-5491.2004.01212.x","volume":"21","author":"K Hashimoto","year":"2004","unstructured":"Hashimoto K, Kasayama S, Yamamoto H, et al. Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension. Diabet Med. 2004;21:581\u20135.","journal-title":"Diabet Med"},{"key":"1843_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ijo.2010.137","volume":"35","author":"NJ Timpson","year":"2010","unstructured":"Timpson NJ, Nordestgaard BG, Harbord RM, et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes. 2010;35:300\u20138.","journal-title":"Int J Obes"},{"key":"1843_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/obr.12003","volume":"14","author":"J Choi","year":"2013","unstructured":"Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev. 2013;14:232\u201344.","journal-title":"Obes Rev"},{"key":"1843_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.diabres.2005.10.025","volume":"72","author":"G Yuan","year":"2006","unstructured":"Yuan G, Zhou L, Tang J, et al. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Res Clin Pract. 2006;72:244\u201350.","journal-title":"Diabetes Res Clin Pract"},{"key":"1843_CR47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/00365513.2013.798870","volume":"73","author":"A Colak","year":"2013","unstructured":"Colak A, Akinci B, Diniz G, et al. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes. Scand J Clin Lab Invest. 2013;73:422\u20137.","journal-title":"Scand J Clin Lab Invest"},{"key":"1843_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.diabres.2009.04.005","volume":"86","author":"N Chakarova","year":"2009","unstructured":"Chakarova N, Tankova T, Atanassova I, et al. Serum lipid and HsCRP levels in prediabetes \u2013 impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). Diabetes Res Clin Pract. 2009;86:56\u201360.","journal-title":"Diabetes Res Clin Pract"},{"key":"1843_CR49","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","volume":"106","author":"K Esposito","year":"2002","unstructured":"Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067\u201372.","journal-title":"Circulation"},{"key":"1843_CR50","doi-asserted-by":"crossref","unstructured":"Chen L, Chen R, Wang H et al. Mechanisms Linking Inflammation to Insulin Resistance. Int J Endocrinol. 2015; 2015: 508409.","DOI":"10.1155\/2015\/508409"},{"key":"1843_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","volume":"25","author":"P Dandona","year":"2004","unstructured":"Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4\u20137.","journal-title":"Trends Immunol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01843-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01843-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01843-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:40:47Z","timestamp":1757248847000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01843-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1843"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01843-0","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Northern Ostrobothnia Hospital District approved the study (Reference number 33\/2008). Informed signed consent was obtained from all the study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}